Galderma, Ipsen extend Dysport collaboration
As part of the expansion, the companies have renewed collaboration in Brazil and Argentina and also extended the partnership to Australia where Galderma will have exclusive promotion and
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective from 1 January 2027.
Purification resins are used for refining desired components/chemicals from culture/reaction solutions for biopharmaceutical and industrial manufacturing processes. Under the alliance, SDK will investment in BIASep as well as